Hexyl aminolevulinate (0.2%) daylight PDT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hexyl aminolevulinate (0.2%) daylight PDT, covering 2016-07-11 to 2016-07-11. Get the full timeline:
Most recent: Clinical Trial Update: Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL [Phase 1, Phase 2]